AT387771B - Verfahren zur herstellung von neuen oxazolidinen - Google Patents
Verfahren zur herstellung von neuen oxazolidinenInfo
- Publication number
- AT387771B AT387771B AT0355384A AT355384A AT387771B AT 387771 B AT387771 B AT 387771B AT 0355384 A AT0355384 A AT 0355384A AT 355384 A AT355384 A AT 355384A AT 387771 B AT387771 B AT 387771B
- Authority
- AT
- Austria
- Prior art keywords
- oxazolidines
- producing new
- producing
- new
- new oxazolidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6070/83A CH655931A5 (en) | 1983-11-10 | 1983-11-10 | Oxazolidines |
| CH449984 | 1984-09-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA355384A ATA355384A (de) | 1988-08-15 |
| AT387771B true AT387771B (de) | 1989-03-10 |
Family
ID=25695620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0355384A AT387771B (de) | 1983-11-10 | 1984-11-09 | Verfahren zur herstellung von neuen oxazolidinen |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4743604A (de) |
| AT (1) | AT387771B (de) |
| AU (1) | AU576531B2 (de) |
| BE (1) | BE900983A (de) |
| CA (1) | CA1249992A (de) |
| DE (1) | DE3438411A1 (de) |
| DK (1) | DK520584A (de) |
| ES (1) | ES8606863A1 (de) |
| FI (1) | FI844152L (de) |
| FR (1) | FR2554814B1 (de) |
| GB (1) | GB2149405B (de) |
| HU (1) | HU193465B (de) |
| IL (1) | IL73427A (de) |
| IT (1) | IT1177033B (de) |
| LU (1) | LU85631A1 (de) |
| MC (1) | MC1641A1 (de) |
| NL (1) | NL8403308A (de) |
| NO (1) | NO844501L (de) |
| NZ (1) | NZ210105A (de) |
| PH (1) | PH22462A (de) |
| PT (1) | PT79485B (de) |
| SE (1) | SE463099B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
| FI892341A (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| SK111195A3 (en) * | 1994-09-13 | 1997-06-04 | Sandoz Technology Ltd | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
| US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
| US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
| US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
| WO2006110859A2 (en) | 2005-04-13 | 2006-10-19 | Glucolight Corporation | Method for data reduction and calibration of an oct-based blood glucose monitor |
| US8571617B2 (en) | 2008-03-04 | 2013-10-29 | Glt Acquisition Corp. | Flowometry in optical coherence tomography for analyte level estimation |
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA979912A (en) * | 1970-06-22 | 1975-12-16 | Frederic P. Hauck | Tetrahydronaphthyloxyaminopropanols and related compounds |
| GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
-
1984
- 1984-10-11 CA CA000465149A patent/CA1249992A/en not_active Expired
- 1984-10-19 DE DE19843438411 patent/DE3438411A1/de not_active Withdrawn
- 1984-10-22 FI FI844152A patent/FI844152L/fi not_active Application Discontinuation
- 1984-10-25 IT IT23307/84A patent/IT1177033B/it active
- 1984-10-31 NL NL8403308A patent/NL8403308A/nl not_active Application Discontinuation
- 1984-11-01 DK DK520584A patent/DK520584A/da not_active Application Discontinuation
- 1984-11-01 US US06/667,186 patent/US4743604A/en not_active Expired - Fee Related
- 1984-11-05 IL IL73427A patent/IL73427A/xx unknown
- 1984-11-05 NZ NZ210105A patent/NZ210105A/xx unknown
- 1984-11-06 BE BE0/213953A patent/BE900983A/fr not_active IP Right Cessation
- 1984-11-06 MC MC841735A patent/MC1641A1/xx unknown
- 1984-11-07 LU LU85631A patent/LU85631A1/de unknown
- 1984-11-08 FR FR8417009A patent/FR2554814B1/fr not_active Expired
- 1984-11-08 ES ES537487A patent/ES8606863A1/es not_active Expired
- 1984-11-09 AT AT0355384A patent/AT387771B/de not_active IP Right Cessation
- 1984-11-09 AU AU35275/84A patent/AU576531B2/en not_active Ceased
- 1984-11-09 SE SE8405632A patent/SE463099B/sv not_active IP Right Cessation
- 1984-11-09 NO NO844501A patent/NO844501L/no unknown
- 1984-11-09 GB GB08428335A patent/GB2149405B/en not_active Expired
- 1984-11-09 PT PT79485A patent/PT79485B/pt unknown
- 1984-11-09 HU HU844174A patent/HU193465B/hu unknown
- 1984-11-09 PH PH31427A patent/PH22462A/en unknown
-
1988
- 1988-02-05 US US07/152,522 patent/US4871755A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT377524B (de) | Verfahren zur herstellung von neuen anthracyclinglycosiden | |
| AT382612B (de) | Verfahren zur herstellung von neuen arylcyclobutylalkylaminen | |
| AT383596B (de) | Verfahren zur herstellung von neuen thiazolidin-derivaten | |
| AT387771B (de) | Verfahren zur herstellung von neuen oxazolidinen | |
| AT382638B (de) | Verfahren zur herstellung von neuen trehaloselipiden | |
| AT384017B (de) | Verfahren zur herstellung von neuen hydroxyaminoestern | |
| ATA206483A (de) | Verfahren zur herstellung von neuen mitosanderivaten | |
| ATA125383A (de) | Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen | |
| ATA5985A (de) | Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen | |
| AT386199B (de) | Verfahren zur herstellung von neuen 2-piperazinopyrimidinen | |
| ATA404284A (de) | Verfahren zur herstellung von neuen gonadoliberin-derivaten | |
| AT386828B (de) | Verfahren zur herstellung von neuen acylaminomitosanen | |
| AT385035B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT384226B (de) | Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden | |
| ATA258985A (de) | Verfahren zur herstellung von neuen substituierten 7-oxomitosanen | |
| ATA279784A (de) | Verfahren zur herstellung von neuen 2-aminomethyl-2-penem-verbindungen | |
| AT385509B (de) | Verfahren zur herstellung von neuen mitosanverbindungen | |
| ATA106084A (de) | Verfahren zur herstellung von neuen gonadoliberin-derivaten | |
| AT387385B (de) | Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen | |
| AT384214B (de) | Verfahren zur herstellung von neuen mercaptoacylcarnitinen | |
| ATA72484A (de) | Verfahren zur herstellung von neuen benzamid-derivaten | |
| ATA52285A (de) | Verfahren zur herstellung von neuen diazepinoindolen | |
| AT381939B (de) | Verfahren zur herstellung von neuen azaspiroalkandionen | |
| AT378776B (de) | Verfahren zur herstellung von neuen anthracyclinglycosiden | |
| AT386410B (de) | Verfahren zur herstellung von neuen ergolinderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |